Noble, Alfonso A.

HRN: 28-71-23  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
CEFTAZIDIME 1GM (VIAL)
03/19/2026
03/26/2026
IV
2g
Q8H
CAP MR
Remove - Pending Acceptance
03/19/2026
LEVOFLOXACIN 500MG (TAB)
03/19/2026
03/26/2026
PO
500mg
OD
CAP MR
Remove - Pending Acceptance
03/19/2026
LEVOFLOXACIN 500MG (TAB)
03/19/2026
03/26/2026
PO
500mg
OD
CAP MR
Remove - Pending Acceptance
03/19/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/19/2026
03/26/2026
IV
4.5
Q8H
CAP HR
Remove - Pending Acceptance
03/19/2026
AZITHROMYCIN 500MG TABLET (TAB)
03/19/2026
03/23/2026
PO
OD
5days
CAP HR
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: